Motley Fool81d agoneutral
Hims & Hers' Chief Accounting Officer Is Leaving. Here's What Her Latest Insider Filing ShowsNotícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
104last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Motley Fool81d agobullish
An Insider at Hims & Hers Just Filed. Here's What It Says About Buying the DipMotley Fool81d agoneutral
Hims & Hers' Policy Chief Just Filed an Insider Transaction. Here's What It Means.Motley Fool81d agoneutral
The CTO of Hims & Hers Just Gave Up Nearly $2.7 Million in Stock. Here's What It Actually MeansMotley Fool81d agoneutral
Hims & Hers' CEO Just Disposed of 78,859 Shares. Here's What Long-Term Investors Should Know.Investing.com82d agoneutral
Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors"Stocktwits83d agoneutral
HIMS Stock Has Quadrupled In 5 Years: How Hims Turned A $3 Stock Into A Telehealth GiantStockStory83d agoneutral
5 Revealing Analyst Questions From Hims & Hers Health’s Q2 Earnings CallStocktwits84d agobullish
HIMS Stock Climbs Overnight: Oscar Health CEO Courts Hims For New Drug MarketplaceInsider Monkey86d agoneutral
Hims & Hers (HIMS) Raised Guidance. Can Growth Survive Its GLP-1 Margin Reset?StockStory87d agoneutral
HIMS Q2 Deep Dive: AI Strategy and International Expansion Shape Telehealth OutlookSimply Wall St.89d agoneutral
Will Hims & Hers’ Higher 2026 Revenue Guidance Amid Rising Losses Change HIMS’s Investment Narrative?MT Newswires89d agoneutral
Hims & Hers Health Sees Mixed Q2 as Gross Margin, FCF Weigh, Morgan Stanley Says